Agreed. LP-002 clinical studies are yet to be completed but shouldn't be much longer.
Since Amarantus has no immediate need for cash, they should wait until they have the full results and the best possible negotiating position.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
